The Division of Hematologic Malignancies 1 (DHM1) regulates Investigational New Drug Applications (INDs), New Drug Applications (NDAs), and Biologic Licensing Applications (BLAs) for Acute Leukemia and Myelodysplasia and Chronic Myeloid Leukemia.
Food and Drug Administration
Center for Drug Evaluation and Research
Division of Hematologic Malignancies 1 (DHM1)
5901-B Ammendale Road
Beltsville, MD 20705-1266
Phone: (301) 796-7550
Fax: (301) 796-9845